Exponent Q3 Beats Estimates, $100M Buyback

Exponent Inc. beat expectations in Q3 FY2025, reporting diluted EPS of $0.55 versus consensus near $0.50–$0.51 and total revenue of $147.1 million (revenues before reimbursements $137.1 million), a year‑over‑year increase. Net income was $28.0 million and EBITDA rose about 8% to $38.8 million; billable hours increased 4% to 376,000. Year‑to‑date figures through Oct. 3 showed only 3% revenue growth and modest declines in EBITDA, net income and EPS. Management said growth was driven by increased dispute‑related and risk‑management work across energy, transportation, life sciences, construction and utilities, and highlighted advising on AI‑related safety and technical challenges. The firm emphasized its deep technical bench—roughly 900 consulting staff including more than 650 doctoral‑level professionals across 90+ disciplines—and expanded its share‑repurchase authorization by $100 million. Shares rose modestly in aftermarket trading but remain well below earlier year‑to‑date levels, leaving investors to weigh the quarterly beat against longer‑term performance trends.